SCHEMBL29996555

SCHEMBL29996555

Cc1cccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c(-c3ccc4c(c3)c3ccccc3n4-c3ccccc3)c2-c2ccc3c(c2)c2ccccc2n3-c2ccccc2)n1

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ PTGER4 P35408 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ ATM Q13315 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ TGFBR1 P36897 11/20 0.36
▸ NPY5R Q15761 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ AVPR1A P37288 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29997163 0.90 KDM4E (0.41) PTGER4KDM4EATML3MBTL1NPY5R
SCHEMBL21421117 0.90 KDM4E (0.41) PTGER4KDM4EATML3MBTL1NPY5R
SCHEMBL20596500 0.89 KDM4E (0.49) PTGER4KDM4EATML3MBTL1NPY5R
SCHEMBL29996550 0.88 PTGER4 (0.39) PTGER4KDM4EATML3MBTL1TGFBR1
SCHEMBL29996884 0.87 PTGER4 (0.39) PTGER4KDM4EATML3MBTL1NPY5R
SCHEMBL29996529 0.87 PTGER4 (0.40) PTGER4KDM4EATML3MBTL1NPY5R
SCHEMBL29996359 0.87 KMT2A (0.43) PTGER4KDM4EATML3MBTL1NPY5R
SCHEMBL29997093 0.87 KMT2A (0.44) PTGER4KDM4EATML3MBTL1NPY5R
SCHEMBL16943259 0.85 KDM4E (0.45) PTGER4KDM4EATML3MBTL1NPY5R
SCHEMBL21421118 0.85 KDM4E (0.40) PTGER4KDM4EATML3MBTL1NPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11498914-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2022-11-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11498914-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 PTGER4 2266/4885KDM4E 4364/4885ATM 1817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback